What’s Propelling Aptinyx Inc (NASDAQ:APTX) After Higher Shorts Reported?

September 16, 2018 - By Mark Mitchell

The stock of Aptinyx Inc (NASDAQ:APTX) registered an increase of 5.96% in short interest. APTX’s total short interest was 335,900 shares in September as published by FINRA. Its up 5.96% from 317,000 shares, reported previously. With 47,400 shares average volume, it will take short sellers 7 days to cover their APTX’s short positions. The short interest to Aptinyx Inc’s float is 2.49%.

The stock decreased 0.17% or $0.05 during the last trading session, reaching $30.03. About 83,981 shares traded. Aptinyx Inc. (NASDAQ:APTX) has 0.00% since September 16, 2017 and is . It has underperformed by 15.62% the S&P500.

Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company has market cap of $162.62 million. It is developing NYX-2925 that is in Phase II clinical trial for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II exploratory clinical trial for fibromyalgia; and NYX-783, an NMDAr receptor that is in Phase I clinical trial for the treatment of post-traumatic stress disorder. It currently has negative earnings. The firm has a collaboration agreement with Allergan plc.

More important recent Aptinyx Inc. (NASDAQ:APTX) news were published by: Benzinga.com which released: “54 Biggest Movers From Yesterday” on September 06, 2018, also Nasdaq.com published article titled: “Aptinyx Presents Preclinical Data from Fast-Track Designated PTSD Program at Military Health System Research …”, Benzinga.com published: “The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin’s Debt Offering, ProQR And Bluebird Report Positive …” on September 05, 2018. More interesting news about Aptinyx Inc. (NASDAQ:APTX) was released by: Nasdaq.com and their article: “Aptinyx Presents Preclinical Data on NMDA Receptor Modulator NYX-2925 at the International Association for the …” with publication date: September 14, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.